presented. PhD student Stefanie Busold from Pr. Ronald van Ree’s lab at Amsterdam University Medical Centers presented a scientific poster titled: “Towards Tolerance: Targeting dendritic cells to combat allergic disease.” Some data reported on her work with cell cultures of human dendritic cells (ex vivo human assay research) documented a potent immune response generated by some of ANGANY’s candidate medications.
